Molecular analysis of dihydropteridine reductase deficiency and restoration of the enzyme activity by gene transfer

1990 ◽  
Vol 13 (5) ◽  
pp. 787-791 ◽  
Author(s):  
H. Mikami ◽  
Y. Matsubara ◽  
K. Hayasaka ◽  
K. Narisawa ◽  
M. Obinata ◽  
...  
Blood ◽  
1979 ◽  
Vol 53 (1) ◽  
pp. 116-121
Author(s):  
HT Abelson ◽  
C Gorka ◽  
GP Beardsley

Normal human platelets were shown to contain the enzyme dihydropteridine reductase. The enzyme was not found in a variety of other cells of hematogenous origin. Partial purification and kinetic and physical data indicated that the platelet enzyme is similar to that previously characterized from liver. Dihydropteridine reductase is important for the regeneration of tetrahydrobiopterin, a required cofactor in hydroxylation reactions involved in biogenic amine formation. The presence of the enzyme may indicate that some synthesis de novo of serotonin and/or catecholamines occurs in platelets, as opposed to a purely storage and transport function. In addition, screening for hyperphenylalaninemia due to dihydropteridine reductase deficiency may become feasible by assaying platelets for enzyme activity.


Blood ◽  
1979 ◽  
Vol 53 (1) ◽  
pp. 116-121 ◽  
Author(s):  
HT Abelson ◽  
C Gorka ◽  
GP Beardsley

Abstract Normal human platelets were shown to contain the enzyme dihydropteridine reductase. The enzyme was not found in a variety of other cells of hematogenous origin. Partial purification and kinetic and physical data indicated that the platelet enzyme is similar to that previously characterized from liver. Dihydropteridine reductase is important for the regeneration of tetrahydrobiopterin, a required cofactor in hydroxylation reactions involved in biogenic amine formation. The presence of the enzyme may indicate that some synthesis de novo of serotonin and/or catecholamines occurs in platelets, as opposed to a purely storage and transport function. In addition, screening for hyperphenylalaninemia due to dihydropteridine reductase deficiency may become feasible by assaying platelets for enzyme activity.


1997 ◽  
Vol 100 (5-6) ◽  
pp. 637-642 ◽  
Author(s):  
Hiroyuki Ikeda ◽  
Y. Matsubara ◽  
Hitoshi Mikami ◽  
Shigeo Kure ◽  
Misao Owada ◽  
...  

1990 ◽  
Vol 149 (10) ◽  
pp. 713-715 ◽  
Author(s):  
L. G. Greeves ◽  
R. J. Leeming ◽  
K. Hyland ◽  
S. I. Dempsey ◽  
D. J. Carson

1979 ◽  
Vol 76 (8) ◽  
pp. 3987-3990 ◽  
Author(s):  
G. A. Scangos ◽  
K. M. Huttner ◽  
S. Silverstein ◽  
F. H. Ruddle

JIMD Reports ◽  
2021 ◽  
Author(s):  
Nicola Vitturi ◽  
Livia Lenzini ◽  
Concetta Luisi ◽  
Miryam Carecchio ◽  
Giorgia Gugelmo ◽  
...  

PEDIATRICS ◽  
1980 ◽  
Vol 65 (4) ◽  
pp. 806-810
Author(s):  
Sheldon Milstien ◽  
Seymour Kaufman ◽  
George K. Summer

Hyperphenylalaninemia due to dihydropteridine reductase deficiency results from the inability to maintain the aromatic amino acid hydroxylase cofactor, tetrahydrobiopterin, in its reduced or active form. Diagnosis of the disease is usually made by direct enzymatic assay on liver biopsies or in cultured skin fibroblasts. Evidence is presented that normal children and classic phenylketonuric children excrete mainly tetrahy-drobiopterin in their urmnes, whereas children with dihydropteridine reductase deficiency excrete only oxidized forms of biopterin. Details of a rapid high performance liquid chromatographic assay for the measurement of the various forms of biopterin in urine are presented. This assay can be used to screen for suspected dihydropteridine reductase mutants.


Sign in / Sign up

Export Citation Format

Share Document